NicOx strengthens NO-donating pipeline
This article was originally published in Scrip
Executive Summary
NicOx has acquired Nitromed's nitric oxide-donating compounds in a deal that hands it the strongest intellectual property for the technology worldwide. The €6 million agreement gives NicOx several patents in its core areas of inflammatory and cardiometabolic disorders.